Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
SNDA vs ENSG vs BKD vs SGRY vs CTRE
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Care Facilities
REIT - Healthcare Facilities
SNDA vs ENSG vs BKD vs SGRY vs CTRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | REIT - Healthcare Facilities |
| Market Cap | $695M | $10.18B | $3.22B | $1.87B | $8.82B |
| Revenue (TTM) | $381M | $5.27B | $3.11B | $3.34B | $468M |
| Net Income (TTM) | $-71M | $363M | $-205M | $-76M | $335M |
| Gross Margin | -8.0% | 15.2% | 14.3% | 22.8% | 86.8% |
| Operating Margin | -15.3% | 8.5% | 1.4% | 11.8% | 69.1% |
| Forward P/E | — | 23.2x | — | 38.0x | 26.6x |
| Total Debt | $690M | $4.15B | $6.66B | $4.02B | $894M |
| Cash & Equiv. | $11M | $504M | $279M | $240M | $198M |
SNDA vs ENSG vs BKD vs SGRY vs CTRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sonida Senior Livin… (SNDA) | 100 | 369.5 | +269.5% |
| The Ensign Group, I… (ENSG) | 100 | 398.7 | +298.7% |
| Brookdale Senior Li… (BKD) | 100 | 370.4 | +270.4% |
| Surgery Partners, I… (SGRY) | 100 | 106.8 | +6.8% |
| CareTrust REIT, Inc. (CTRE) | 100 | 212.1 | +112.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SNDA vs ENSG vs BKD vs SGRY vs CTRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SNDA lags the leaders in this set but could rank higher in a more targeted comparison.
ENSG is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 7.5% 10Y total return vs CTRE's 265.1%
- Better valuation composite
- 6.8% ROA vs SNDA's -8.4%, ROIC 7.0% vs -5.8%
BKD ranks third and is worth considering specifically for momentum.
- +105.1% vs SGRY's -38.2%
Among these 5 stocks, SGRY doesn't own a clear edge in any measured category.
CTRE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.14, yield 3.2%
- Rev growth 108.8%, EPS growth 96.3%, 3Y rev CAGR 36.5%
- Lower volatility, beta 0.14, Low D/E 22.1%, current ratio 1.54x
- PEG 1.25 vs ENSG's 1.68
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 108.8% FFO/revenue growth vs BKD's 4.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 71.5% margin vs SNDA's -18.7% | |
| Stability / Safety | Beta 0.14 vs SNDA's 1.10, lower leverage | |
| Dividends | 3.2% yield, 2-year raise streak, vs ENSG's 0.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +105.1% vs SGRY's -38.2% | |
| Efficiency (ROA) | 6.8% ROA vs SNDA's -8.4%, ROIC 7.0% vs -5.8% |
SNDA vs ENSG vs BKD vs SGRY vs CTRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SNDA vs ENSG vs BKD vs SGRY vs CTRE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTRE leads in 2 of 6 categories
SGRY leads 1 • ENSG leads 1 • SNDA leads 0 • BKD leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTRE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 13.8x SNDA's $381M. CTRE is the more profitable business, keeping 71.5% of every revenue dollar as net income compared to SNDA's -18.7%. On growth, CTRE holds the edge at +99.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $381M | $5.3B | $3.1B | $3.3B | $468M |
| EBITDAEarnings before interest/tax | -$1M | $558M | $384M | $572M | $428M |
| Net IncomeAfter-tax profit | -$71M | $363M | -$205M | -$76M | $335M |
| Free Cash FlowCash after capex | -$9M | $406M | $56M | $208M | $400M |
| Gross MarginGross profit ÷ Revenue | -8.0% | +15.2% | +14.3% | +22.8% | +86.8% |
| Operating MarginEBIT ÷ Revenue | -15.3% | +8.5% | +1.4% | +11.8% | +69.1% |
| Net MarginNet income ÷ Revenue | -18.7% | +6.9% | -6.6% | -2.3% | +71.5% |
| FCF MarginFCF ÷ Revenue | -2.3% | +7.7% | +1.8% | +6.2% | +85.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | +18.4% | -2.0% | +4.5% | +99.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.5% | +21.9% | +89.7% | +6.7% | +2.9% |
Valuation Metrics
SGRY leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 25.2x trailing earnings, CTRE trades at a 16% valuation discount to ENSG's 29.8x P/E. Adjusting for growth (PEG ratio), CTRE offers better value at 1.19x vs ENSG's 2.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $695M | $10.2B | $3.2B | $1.9B | $8.8B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $13.8B | $9.6B | $5.7B | $9.5B |
| Trailing P/EPrice ÷ TTM EPS | -8.67x | 29.85x | -12.21x | -23.46x | 25.17x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 23.19x | — | 37.99x | 26.58x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.16x | — | — | 1.19x |
| EV / EBITDAEnterprise value multiple | — | 25.71x | 25.53x | 10.00x | 23.03x |
| Price / SalesMarket cap ÷ Revenue | 1.82x | 2.01x | 1.03x | 0.57x | 18.51x |
| Price / BookPrice ÷ Book value/share | 11.76x | 4.59x | — | 0.52x | 2.00x |
| Price / FCFMarket cap ÷ FCF | — | 27.46x | — | 9.57x | 23.27x |
Profitability & Efficiency
ENSG leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-235 for BKD. CTRE carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNDA's 12.26x. On the Piotroski fundamental quality scale (0–9), ENSG scores 5/9 vs SNDA's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -76.4% | +16.6% | -234.5% | -2.2% | +8.6% |
| ROA (TTM)Return on assets | -8.4% | +6.8% | -3.4% | -0.9% | +6.7% |
| ROICReturn on invested capital | -5.8% | +7.0% | +0.2% | +4.1% | +6.1% |
| ROCEReturn on capital employed | -7.7% | +10.2% | +0.3% | +5.2% | +7.7% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 4 | 5 | 5 |
| Debt / EquityFinancial leverage | 12.26x | 1.86x | — | 1.14x | 0.22x |
| Net DebtTotal debt minus cash | $679M | $3.7B | $6.4B | $3.8B | $696M |
| Cash & Equiv.Liquid assets | $11M | $504M | $279M | $240M | $198M |
| Total DebtShort + long-term debt | $690M | $4.2B | $6.7B | $4.0B | $894M |
| Interest CoverageEBIT ÷ Interest expense | -0.86x | 88.33x | 0.19x | 1.35x | 8.44x |
Total Returns (Dividends Reinvested)
Evenly matched — SNDA and ENSG and BKD each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $2,773 for SGRY. Over the past 12 months, BKD leads with a +105.1% total return vs SGRY's -38.2%. The 3-year compound annual growth rate (CAGR) favors SNDA at 73.9% vs SGRY's -25.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.6% | +0.3% | +25.0% | -6.2% | +9.9% |
| 1-Year ReturnPast 12 months | +52.7% | +27.5% | +105.1% | -38.2% | +40.3% |
| 3-Year ReturnCumulative with dividends | +426.3% | +88.9% | +239.7% | -59.2% | +117.8% |
| 5-Year ReturnCumulative with dividends | -23.8% | +103.2% | +85.2% | -72.3% | +96.6% |
| 10-Year ReturnCumulative with dividends | -87.7% | +752.0% | -26.0% | -0.6% | +265.1% |
| CAGR (3Y)Annualised 3-year return | +73.9% | +23.6% | +50.3% | -25.8% | +29.6% |
Risk & Volatility
CTRE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CTRE is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than SNDA's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CTRE currently trades 94.7% from its 52-week high vs SGRY's 59.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 0.42x | 0.67x | 1.04x | 0.14x |
| 52-Week HighHighest price in past year | $38.98 | $218.00 | $17.00 | $24.18 | $41.72 |
| 52-Week LowLowest price in past year | $23.53 | $133.81 | $6.07 | $11.41 | $27.72 |
| % of 52W HighCurrent price vs 52-week peak | +93.8% | +80.0% | +79.7% | +59.2% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 63.5 | 23.3 | 54.0 | 63.3 | 54.5 |
| Avg Volume (50D)Average daily shares traded | 602K | 358K | 3.3M | 1.5M | 2.5M |
Analyst Outlook
Evenly matched — ENSG and CTRE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SNDA as "Hold", ENSG as "Buy", BKD as "Buy", SGRY as "Buy", CTRE as "Buy". Consensus price targets imply 30.4% upside for BKD (target: $18) vs -5.2% for SNDA (target: $35). For income investors, CTRE offers the higher dividend yield at 3.22% vs ENSG's 0.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $34.67 | $222.33 | $17.67 | $18.60 | $42.50 |
| # AnalystsCovering analysts | 3 | 13 | 12 | 22 | 19 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | +0.1% | — | — | +3.2% |
| Dividend StreakConsecutive years of raises | 1 | 12 | 0 | 0 | 2 |
| Dividend / ShareAnnual DPS | $0.31 | $0.24 | — | — | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +0.2% | 0.0% | +0.0% |
CTRE leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). SGRY leads in 1 (Valuation Metrics). 2 tied.
SNDA vs ENSG vs BKD vs SGRY vs CTRE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SNDA or ENSG or BKD or SGRY or CTRE a better buy right now?
For growth investors, CareTrust REIT, Inc.
(CTRE) is the stronger pick with 108. 8% revenue growth year-over-year, versus 4. 8% for Brookdale Senior Living Inc. (BKD). CareTrust REIT, Inc. (CTRE) offers the better valuation at 25. 2x trailing P/E (26. 6x forward), making it the more compelling value choice. Analysts rate The Ensign Group, Inc. (ENSG) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SNDA or ENSG or BKD or SGRY or CTRE?
On trailing P/E, CareTrust REIT, Inc.
(CTRE) is the cheapest at 25. 2x versus The Ensign Group, Inc. at 29. 8x. On forward P/E, The Ensign Group, Inc. is actually cheaper at 23. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: CareTrust REIT, Inc. wins at 1. 25x versus The Ensign Group, Inc. 's 1. 68x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — SNDA or ENSG or BKD or SGRY or CTRE?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -72. 3% for Surgery Partners, Inc. (SGRY). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus SNDA's -87. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SNDA or ENSG or BKD or SGRY or CTRE?
By beta (market sensitivity over 5 years), CareTrust REIT, Inc.
(CTRE) is the lower-risk stock at 0. 14β versus Sonida Senior Living, Inc. 's 1. 10β — meaning SNDA is approximately 704% more volatile than CTRE relative to the S&P 500. On balance sheet safety, CareTrust REIT, Inc. (CTRE) carries a lower debt/equity ratio of 22% versus 12% for Sonida Senior Living, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SNDA or ENSG or BKD or SGRY or CTRE?
By revenue growth (latest reported year), CareTrust REIT, Inc.
(CTRE) is pulling ahead at 108. 8% versus 4. 8% for Brookdale Senior Living Inc. (BKD). On earnings-per-share growth, the picture is similar: CareTrust REIT, Inc. grew EPS 96. 3% year-over-year, compared to -681. 5% for Sonida Senior Living, Inc.. Over a 3-year CAGR, CTRE leads at 36. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SNDA or ENSG or BKD or SGRY or CTRE?
CareTrust REIT, Inc.
(CTRE) is the more profitable company, earning 67. 3% net margin versus -20. 0% for Sonida Senior Living, Inc. — meaning it keeps 67. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTRE leads at 67. 2% versus -15. 3% for SNDA. At the gross margin level — before operating expenses — CTRE leads at 59. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SNDA or ENSG or BKD or SGRY or CTRE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, CareTrust REIT, Inc. (CTRE) is the more undervalued stock at a PEG of 1. 25x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, The Ensign Group, Inc. (ENSG) trades at 23. 2x forward P/E versus 38. 0x for Surgery Partners, Inc. — 14. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BKD: 30. 4% to $17. 67.
08Which pays a better dividend — SNDA or ENSG or BKD or SGRY or CTRE?
In this comparison, CTRE (3.
2% yield), SNDA (0. 9% yield), ENSG (0. 1% yield) pay a dividend. BKD, SGRY do not pay a meaningful dividend and should not be held primarily for income.
09Is SNDA or ENSG or BKD or SGRY or CTRE better for a retirement portfolio?
For long-horizon retirement investors, CareTrust REIT, Inc.
(CTRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 3. 2% yield, +265. 1% 10Y return). Both have compounded well over 10 years (CTRE: +265. 1%, SGRY: -0. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SNDA and ENSG and BKD and SGRY and CTRE?
These companies operate in different sectors (SNDA (Healthcare) and ENSG (Healthcare) and BKD (Healthcare) and SGRY (Healthcare) and CTRE (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SNDA is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock; BKD is a small-cap quality compounder stock; SGRY is a small-cap quality compounder stock; CTRE is a small-cap high-growth stock. SNDA, CTRE pay a dividend while ENSG, BKD, SGRY do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.